Vertebral Compression Fracture Devices Market

Global Vertebral Compression Fracture Devices Market Size (2023 to 2028)

The global vertebral compression fracture devices market is estimated to grow at a CAGR of 8.5% from 2023 to 2028. The market is expected to grow to USD 1381 million by 2028 from USD 918.9 million in 2023.

A spinal condition called a fracture brings on a vertebral compression fracture in the spinal cord caused by osteoporosis, arthritis, and trauma. The most frequent reason for compression fractures of the vertebrae is osteoporosis. This is because bones that have osteoporosis are more prone to breaking easily. Other causes include tumors in the spine and spinal injuries (including those sustained in sports and auto accidents). The vertebrae may be the tumor's first location. After that, however, it usually spreads to the bone from another area of the body. Vertebroplasty and kyphoplasty are frequent forms of treatment. In older patients, vertebral compression fractures are more common and painful. Most patients with spinal compression fractures require non-operative treatment in addition to bracing and pain relief. As a result, numerous businesses have invested in searching for better, less invasive ways to treat spinal compression fractures, which is what runs the market. Vertebroplasty and kyphoplasty are frequently beneficial for individuals with prolonged back pain and bone marrow edema, and the surgery usually lasts no longer than three weeks.

Impact of covid-19 on the global vertebral compression fracture market:

The COVID-19 pandemic has influenced all areas of the business sector. The global movement limitations, traveling ban and imposed lockdown have disrupted the manufacture, importation, and exportation of vertebral compression fracture devices. Therefore, the COVID-19 pandemic has had a negative impact on the global market expansion for vertebral compression fracture devices. Furthermore, the total market for these devices is expected to be hampered in the upcoming years by the economic recession and a notable decline in the demand for vertebral compression fracture devices used in various elective treatment procedures. However, shortly, industry recovery may be aided by patients with spinal fractures becoming more aware of the dangers of coronavirus. For example, vertebral fractures in COVID-19 patients double the risk of death because they affect cardiorespiratory function and disease outcomes, according to research in the Journal of Clinical Endocrinology & Metabolism. Thus, in the years to come, factors like these can increase the demand for cutting-edge spinal compression fracture devices.

MARKET DRIVERS:

The vertebral compression fracture devices market is expected to grow due to factors like an aging population, osteoporosis and arthritis cases, increased patient awareness of spine operations like artificial replacement of disc improvements, and increased physician training. In addition, the trend toward minimally invasive spine operations has contributed to the market growth for vertebral compression fracture devices worldwide. 

The demand for vertebral compression fracture devices has grown around the world as a result of the prevalence of several degenerative spine conditions, including degenerative disc disease, arthritis, herniated discs, vertebral fractures, ankylosing spondylitis, spondylosis, back pain, osteoporosis, scoliosis, neck pain, spinal cord cancer, spinal cord injury, hematoma, and kyphosis. In addition, infection, unintentional falls, inflammation, traumatic spine injuries, aging-related wear and tear, vitamin insufficiency, autoimmune illnesses, and a blocked blood supply to the spine are the causes of these spinal problems, which increases the demand for vertebral compression fracture devices globally.

MARKET RESTRAINTS:

In contrast, it is anticipated that unrealized potential in the emerging market will create new opportunities for market participants. However, the market is also constricted by the fact that the treatment of spinal compression fractures carries significant hazards. The complications and risks in the process hinder the market's growth. The likelihood of postoperative complications, such as nerve root irritation, vertebral posterior element fracture, bleeding, and osteoporosis acceleration, is relatively significant. This is anticipated to limit the use of vertebral compression fracture operations globally. Over the projected period, this is expected to impede further the market growth for spinal compression fracture devices. In addition, in the medical industry, the risk of infection might rise with every surgery that involves inserting a device under the skin. Unfavorable reimbursement conditions also impede market expansion. 

REPORT COVERAGE:

This research report on the global vertebral compression fracture devices market has been segmented and sub-segmented based on the product type, surgery, and region.

Global Vertebral Compression Fracture Devices Market - By Product:

• Vertebroplasty Devices
• Balloon Kyphoplasty Devices

Throughout the forecast period, the balloon kyphoplasty devices segment is anticipated to grow to hold the most significant market revenue share. This segment is expanding due to factors including rising osteoporosis and arthritis cases. In addition, the market is expected to grow in the forecast period partly because of the rising elderly population. Therefore, throughout the projection period, it is predicted that the vertebroplasty sector will account for sizable revenue shares in the market.

Global Vertebral Compression Fracture Devices Market - By Surgery:

• Minimally Invasive Spine Surgery
• Open Spine Surgery

In 2020, the Global Vertebral Compression Fracture Devices Market by Surgery was dominated by minimally invasive spine surgery. A CAGR of 6.2 percent is anticipated for the open spine surgery market throughout the forecast period (2021 - 2027) due to an upsurge in spinal illnesses that require early detection. Additionally, in the following years, the segment would benefit from larger revenue shares because of the population's increasing awareness of the treatments.

Global Vertebral Compression Fracture Devices Market - By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East and Africa

Geographically, North America is predicted to lead the market due to its expanding population and reimbursement schemes, along with the presence of key market players in the regions like the U.S. and Canada. 

Europe is also expected to contribute to the market due to increased reimbursement coverage, new and advanced technologies, rising population, and the number of chronic diseases in countries like the U.K., Italy, Germany, and France.

Due to an increase in awareness levels, improved healthcare infrastructure, and booming medical tourism because of the relatively low cost of procedures in Asia's emerging economies, like India, Japan, South Korea, China, etc., the market share of vertebral compression fracture devices is expected to increase significantly in the Asia Pacific region.

KEY MARKET PLAYERS:

Companies playing a significant role in the vertebral compression fracture devices market profiled in this report are Stryker Corporation, Merit Medical Systems, Globus Medical, Benvenue Medical Inc., Alphatec Holdings Inc., Johnson & Johnson (Deputy Synthes), Medtronic Plc, Spirit Spine Holdings Corporation Inc, Spine Wave Inc, Zimmer Biomet Holdings Inc., Izi Medical Products, Llc, Cook, and Carefusion.

RECENT MARKET DEVELOPMENTS:

• In April 2022, Tanawat Amphansap et al. in Bangkok, Thailand, conducted research to study the bone mineral density of women in the postmenopausal stage with or without the distal radius fracture to evaluate the role of the vertebral fracture assessment in the diagnosis of osteoporosis. Thus the vertebral fracture assessment has become an efficient tool in assessing postmenopausal women for osteoporosis. 
• In December 2021, A.I. systems for vertebral fractures were out-licensed by the Belgium-based biopharmaceutical company UCB, S.A.; the company has out-licensed its A.I. called bonebot to ImageBiopsy Lab in Austria. With this initiative, the company hopes to reduce the number of undiagnosed vertebrae problems. A.I. has shown great potential in the healthcare systems, including osteoporosis treatments, and the company aims to establish A.I.'s help in the vertebral compression fracture devices market.